CFAR HIV/TB Co-Infection Consortium
Nearly one third of the world's population is infected with tuberculosis, and TB is the main cause of death among HIV-infected people in the developing world, where more than 50% of people with active TB are HIV co-infected. The pathogenesis, immune control, diagnosis and treatment of TB in HIV-infected people is therefore one of the most critical issues in the field of HIV/AIDS research.
CFAR investigators interested in the interface of TB and HIV have come together to form a national working group, with the goal of stimulating inter-CFAR collaborations on this critical coinfection. The working group is organized around 4 smaller interest groups:
- Molecular pathogenesis of TB/HIV coinfection;
- Immunopathogenesis of coinfection;
- Diagnosis of TB in HIV infected children and adults;
- Treatment, clinical trials and implementation science.
The goals are developing shared research agendas, identifying potential inter-CFAR shared resources, and stimulating collaborative projects. Follow each link for information on TB/HIV co-infection research ongoing at each CFAR, and opportunities for shared resources and collaborative projects.
This working group interacts through conference calls and a one-day in person Inter-CFAR TB/HIV Workshop held on September 30, 2009, hosted by the Baylor-UT CFAR in Houston. If you are interested in joining the Inter CFAR HIV/TB Working group or participating in conference calls, please contact:
Ron Collman (collmanr@upenn.edu)
Dorothy Lewis (dlewis@bcm.tmc.edu)
Sarah Fortune (sfortune@hsph.harvard.edu)
If you'd like to subscribe to the email list, please follow this link: